Tumor angiogenesis is the uncontrolled growth of blood vessels in tumors, serving to supply nutrients and oxygen, and remove metabolic wastes. Kaposi's sarcoma (KS), a multifocal angioproliferative disorder characterized by spindle cell proliferation, neo-angiogenesis, inflammation, and edema, is associated with infection by Kaposi's sarcoma-associated herpesvirus (KSHV). Recent studies indicate that KSHV infection directly promotes angiogenesis and inflammation through an autocrine and paracrine mechanism by inducing pro-angiogenic and pro-inflammatory cytokines. Many of these cytokines are also expressed in KS lesions, implicating a direct role of KSHV in the pathogenesis of this malignancy. Several KSHV genes are involved in KSHV-induced angiogenesis. These studies have provided insights into the pathogenesis of KS, and identified potential therapeutic targets for this malignancy.
ORF-K15
ORF-K15 gene is located at the most right side of the viral genome, and has two distinct isoforms. The M and P (for "minor" and "predominant") forms of K15 are 67% divergent. The more common variant, K15-P, is considered to be the original K15 gene, whereas the other, K15-M, is thought to represent the result of a recombination event with a related rhadinovirus (29). K15 is able to interact with TRAFs (tumor necrosis factor receptor-associated factor) and Src kinases, and activates AP-1, NF-κB, and JNK and ERK MAPK pathways (6, 66). The down-stream target genes of K15 signaling are investigated using DNA oligonucleotide microarrays (7). K15 is shown to be able to induce the expression of multiple cytokines and chemokines, including IL-8, IL-6, CCL20, CCL2, CXCL3, and IL-1α/β, as well as Dscr1 and Cox-2 (7). 
